Topics

Latest "Solentim" News Stories

06:01 EST 26th February 2020 | BioPortfolio

Here are the most relevant search results for "Solentim" found in our extensive news archives from over 250 global news sources.

More Information about Solentim on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Solentim for you to read. Along with our medical data and news we also list Solentim Clinical Trials, which are updated daily. BioPortfolio also has a large database of Solentim Companies for you to search.

Showing "Solentim" News Articles, all 9

Extremely Relevant

Solentim wins place in Deloitte UK Technology Fast 50

Solentim named as one of the top 50 fastest growing UK technologies companies of 2018


Relevant

Valitacell and Solentim secure €3.5m funding to optimise the development of new biologics and cell therapies

A consortium, consisting of Valitacell, Solentim and Microcoat, has been awarded €2.5million under the highly competitive H2020 Fast Track to Innovation (FTI) initiative, and a further €1million from other sources

Dr Mark Truesdale joins Solentim as new Chief Marketing Officer

Bournemouth, UK, 1st October 2019 / Sciad Newswire / Solentim, the global leader in cell line development (CLD) instrumentation, is delighted to announce that Dr Mark Truesdale will join the Company as the new Chief Marketing Officer, effective immediately.


Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

Bournemouth, UK and Newark, CA, USA, 14th January 2019 / Sciad Newswire / Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreement.

Solentim and SAL Scientific announce partnership for novel growth supplements in cell line development

Bournemouth, UK, and Fordingbridge, UK, 25th April 2019 / Sciad Newswire / Solentim, the global leader in cell line development (CLD) imaging instrumentation, and SAL Scientific, a leading provider of growth enhancing animal-free cell culture reagents, are pleased to announce a new strategic partnership.

Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies

Dublin, Ireland and Bournemouth, UK, 21st February 2019 / Sciad Newswire / Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announce a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines.

Dr Mark Truesdale joins Solentim as chief marketing officer

Solentim names new Chief Marketing Officer

Dr Mark Truesdale will join the cell line development (CLD) instrumentation specialist

Reliable Single Cell Outgrowth: Dark Art or Science?

Sponsor: Solentim The post Reliable Single Cell Outgrowth: Dark Art or Science? appeared first on GEN - Genetic Engineering and Biotechnology News.


Quick Search

News Quicklinks